Showing results (1861-1870 of 1,880) with videos related to

Sort By:
Pageof 188
Journal of Medicinal Chemistry|November 4, 2021
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple SclerosisBrian T Hopkins, Eris Bame, Bekim Bajrami, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 2, 2023
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjectsXin-Mei Yang, Yang Yang, Bu-Fan Yao, et al.
Nature Plants|March 10, 2026
Amazon rainforests are rejuvenating their canopies by producing more photosynthetically efficient young leaves under climate changeXueqin Yang, Jie Tian, Philippe Ciais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238James Larkin, Michele Del Vecchio, Mario Mandalá, et al.
European Urology|August 26, 2018
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell CarcinomaLe Qu, Ze-Lin Wang, Qi Chen, et al.
Clinical Pharmacokinetics|May 27, 2021
Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual PredictionBo-Hao Tang, Zheng Guan, Karel Allegaert, et al.
Journal of Respiratory Biology and Translational Medicine|December 23, 2024
Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in ShanghaiJin-San Zhang, Qhaweni Dhlamini, Qiang Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2022
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)Jeffrey S Weber, Dirk Schadendorf, Michele Del Vecchio, et al.
Cell Systems|October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell LinesMehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Signal Transduction and Targeted Therapy|September 26, 2021
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gammaJiejie Geng, Liang Chen, Yufeng Yuan, et al.
Pageof 188